Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam
Primary Purpose
Traumatic Brain Injury, Computed Tomography, Procedural Sedation
Status
Withdrawn
Phase
Phase 2
Locations
Brazil
Study Type
Interventional
Intervention
Midazolam
Chloral Hydrate
Sponsored by
About this trial
This is an interventional diagnostic trial for Traumatic Brain Injury focused on measuring Deep Sedation, Pediatrics, Emergency Hospital Services, Midazolam, Chloral hydrate, Randomized controlled trial
Eligibility Criteria
Inclusion Criteria:
- children undergoing CT scanning for TBI
Exclusion Criteria:
- epistaxis
- suspected or confirmed skull or nasal fracture
- Moderate to severe traumatic brain injury
- hemodynamically unstable
Sites / Locations
- University of Sao Paulo
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Chloral hydrate
Midazolam
Arm Description
Children undergoing CT scanning will receive in this arm 50 mg per kg of rectal chloral hydrate.
Children undergoing CT scanning will receive in this arm 0,4 mg/kg of nasal midazolam.
Outcomes
Primary Outcome Measures
Adverse Events
Such as hypoxemia, respiratory depression, vomiting, hypotension
Secondary Outcome Measures
Efficacy of both drugs
Patients vital signs and adverse events will be monitored through patient stay in the emergency department. Mean time after sedation is about three hours.
Variables collected include Ramsay score for sedation. To consider hospital discharge, we will try to validate Aldrette score and compare the scores between the two arms. Mean time to onset of sedation and time of emergency department stay will also be compared as a mark of efficacy of these two drugs.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01402596
Brief Title
Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam
Official Title
Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam - a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2011
Overall Recruitment Status
Withdrawn
Why Stopped
Institution decided on starting a new protocol of sedation, with another methods and that´s why this study has not started.
Study Start Date
August 2011 (undefined)
Primary Completion Date
August 2012 (Anticipated)
Study Completion Date
August 2012 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
University of Sao Paulo
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Thousands of children receive sedation for diagnostic and therapeutic interventions annually, and this number is expected to increase. Children are at higher risk for sedation-related complications than adults. In different scenarios, multiple drugs are used to achieve sedation, each one with particular adverse events that must be monitored and reported.
Children that need CT scans for traumatic brain injuries often need sedation, without needing and IV line for that. Chloral hydrate is an hypnotic agent used since 1832 with low incidence of adverse events; however, despite its worldwide use, it's being abandoned due to bitter taste, long time of sedation onset, vomiting and mild sedation. Intranasal midazolam, on the other hand, produces high and fast concentrations on CSF with greater rates of success but probably with higher adverse events. There are no prospective studies with large series of patients using intranasal midazolam.
The aim of this study is to determine if nasal midazolam is a safer approach and more effective sedative regimen when compared to rectal chloral hydrate to children undergoing CT scans.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Traumatic Brain Injury, Computed Tomography, Procedural Sedation
Keywords
Deep Sedation, Pediatrics, Emergency Hospital Services, Midazolam, Chloral hydrate, Randomized controlled trial
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Chloral hydrate
Arm Type
Active Comparator
Arm Description
Children undergoing CT scanning will receive in this arm 50 mg per kg of rectal chloral hydrate.
Arm Title
Midazolam
Arm Type
Active Comparator
Arm Description
Children undergoing CT scanning will receive in this arm 0,4 mg/kg of nasal midazolam.
Intervention Type
Drug
Intervention Name(s)
Midazolam
Intervention Description
0,4 mg per kg - intranasal midazolam - once
Intervention Type
Drug
Intervention Name(s)
Chloral Hydrate
Intervention Description
50 mg per kg, rectal
Primary Outcome Measure Information:
Title
Adverse Events
Description
Such as hypoxemia, respiratory depression, vomiting, hypotension
Time Frame
Participants will be followed for the duration of hospital (emergency department) stay, an expected average of 2-3 hours
Secondary Outcome Measure Information:
Title
Efficacy of both drugs
Description
Patients vital signs and adverse events will be monitored through patient stay in the emergency department. Mean time after sedation is about three hours.
Variables collected include Ramsay score for sedation. To consider hospital discharge, we will try to validate Aldrette score and compare the scores between the two arms. Mean time to onset of sedation and time of emergency department stay will also be compared as a mark of efficacy of these two drugs.
Time Frame
Participants will be followed for the duration of hospital (emergency department) stay, an expected average of 2-3 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Month
Maximum Age & Unit of Time
3 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
children undergoing CT scanning for TBI
Exclusion Criteria:
epistaxis
suspected or confirmed skull or nasal fracture
Moderate to severe traumatic brain injury
hemodynamically unstable
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eduardo Mekitarian Filho, MSc
Organizational Affiliation
University of Sao Paulo
Official's Role
Study Director
Facility Information:
Facility Name
University of Sao Paulo
City
Sao Paulo
State/Province
SP
ZIP/Postal Code
05508000
Country
Brazil
12. IPD Sharing Statement
Learn more about this trial
Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam
We'll reach out to this number within 24 hrs